Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.
By Mill Chart
Last update: Apr 12, 2024
Stay updated with the stocks that are on the move in Friday's pre-market session.
Pre-market gainers
| Ticker | Change | Comment |
|---|---|---|
| MI | 3.0K% | During Friday's pre-market session, NFT LTD-A (NYSEARCA:MI) experienced a 3.0K% increase, with the stock price reaching $4.91. The stock is trading 40.23% lower than a month ago. |
| PXMD | 126.0% | During Friday's pre-market trading, PAXMEDICA INC (NASDAQ:PXMD) demonstrated strong momentum, with the stock price rising 126.0% to $0.93. A press release (PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission) was released yesterday. |
| BENF | 66.57% | BENEFICIENT - CLASS A's (NASDAQ:BENF) shares rose 66.57% to $0.12 during Friday's pre-market session. The stock is trading 83.15% lower than 3 months ago. |
| HOLOW | 50.87% | The pre-market session on Friday saw a significant rise in GOLDEN PATH ACQ -CW28's (NASDAQ:HOLOW) shares, climbing 50.87% to $0.11. In the last month the stock lost 29.62%. |
| ALLR | 43.23% | During Friday's pre-market session, ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) exhibited strong growth, with the stock price climbing 43.23% to $3.29. After yesterday's drop of -28.89%, it looks like it is bouncing back in today's pre-market session. |
| HKD | 23.66% | Exciting news for AMTD DIGITAL INC-ADR (NYSE:HKD) as their shares soared 23.66% to $3.92 during the pre-market session on Friday. The stock is trading 21.34% lower than 3 months ago. |
| TPET | 20.47% | During Friday's pre-market session, TRIO PETROLEUM CORP (NYSEARCA:TPET) experienced a 20.47% increase, with the stock price reaching $0.28. Today's pre-market session builds upon the previous day's success, as NYSEARCA:TPET continues its upward trajectory following a 26.08% gain. |
| PEPG | 16.76% | PEPGEN INC's (NASDAQ:PEPG) stock price is advancing with 16.76% to a price of $14.84. The stock is trading 85.01% higher than 3 months ago. |
| AKAN | 14.97% | The pre-market session on Friday saw a significant rise in AKANDA CORP's (NASDAQ:AKAN) shares, climbing 14.97% to $0.17. The positive trend witnessed yesterday with a 26.25% gain persists in today's pre-market, indicating sustained growth for NASDAQ:AKAN. |
| GL | 12.87% | Exciting news for GLOBE LIFE INC (NYSE:GL) as their shares soared 12.87% to $55.5 during the pre-market session on Friday. After experiencing a -53.14% loss in the previous session, NYSE:GL is showing resilience and signs of recovery in today's pre-market session. Yesterday the company had a press release: GLOBE LIFE ALERT: Bragar Eagel & Squire, P.C. is Investigating Globe Life, Inc. on Behalf of Globe Life Stockholders and Encourages Investors to Contact the Firm. |
Our premarket gainers page will show you the full list.
Pre-market losers
| Ticker | Change | Comment |
|---|---|---|
| MOTS | -35.72% | MOTUS GI HOLDINGS INC's (NASDAQ:MOTS) shares fell 35.72% to $0.27 during Friday's pre-market session. In the last month the share price dropped with 33.01%. |
| MGRM | -15.03% | MONOGRAM ORTHOPAEDICS INC's (NASDAQ:MGRM) stock price decreased by 15.03% to $3.46. Yesterday's significant 79.3% gain in NASDAQ:MGRM is met with a 15.03% decline in today's pre-market session, reflecting a shift in market sentiment. |
| RLYB | -14.09% | RALLYBIO CORP's (NASDAQ:RLYB) stock price is declining with 14.09% to a price of $2.56. Following yesterday's notable 82.82% increase, NASDAQ:RLYB undergoes a 14.09% decrease in today's pre-market session, suggesting a temporary pullback. Two days ago the company had a press release: Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). |
| ADIL | -12.75% | ADIAL PHARMACEUTICALS INC's (NASDAQ:ADIL) shares fell 12.75% to $2.6. After experiencing a 27.9% increase in yesterday's session, NASDAQ:ADIL is showing a reversal in today's pre-market session with a 12.75% decrease. |
| LXEH | -12.51% | LIXIANG EDUCATION HOLDIN-ADR's (NASDAQ:LXEH) stock price recorded a 12.51% decrease, falling to $0.57. Following yesterday's gain of 69.49%, NASDAQ:LXEH experiences a 12.51% decrease in today's pre-market session, indicating a pullback from the previous session's performance. |
| RENT | -10.73% | Despite yesterday's decline, RENT THE RUNWAY INC-A (NASDAQ:RENT) experienced a further 10.73% decrease in share price during Friday's pre-market session, reaching $17.3. Following an impressive 162.0% run-up in yesterday's session, NASDAQ:RENT experiences a pullback in today's pre-market session, showcasing the market's dynamic nature. Two days ago the company had a press release: Rent the Runway, Inc. Announces Fourth Quarter and Full Year 2023 Results. |
| LKCO | -10.0% | The pre-market session on Friday witnessed a 10.0% decrease in LUOKUNG TECHNOLOGY CORP's (NASDAQ:LKCO) shares, with the stock price falling to $0.5. The stock is trading 26.75% lower than a month ago. |
| MRIN | -9.57% | MARIN SOFTWARE INC's (NASDAQ:MRIN) stock price decreased by 9.57% to $0.54. In the last month the share price increased with 93.74%. |
| ELYM | -9.39% | The stock price of ELIEM THERAPEUTICS INC (NASDAQ:ELYM) is experiencing a decline of 9.39%, reaching $4.15 in today's pre-market session on Friday. Following an impressive 71.54% run-up in yesterday's session, NASDAQ:ELYM experiences a pullback in today's pre-market session, showcasing the market's dynamic nature. A press release (ELYM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Eliem Therapeutics, Inc. Is Fair to Shareholders) was released yesterday. |
| AKLI | -8.63% | AKILI INC's (NASDAQ:AKLI) shares fell 8.63% to $0.23 during Friday's pre-market session. In the last 3 months the share price dropped with 35.05%. |
To see the full list of premarket losers you can use our premarket losers page.
PEPGEN INC
NASDAQ:PEPG (4/29/2024, 7:19:40 PM)
After market: 11.68 0 (0%)11.68
-0.25 (-2.1%)
PEPG News
18 days ago - ChartmillWondering what's happening in today's pre-market session? Stay tuned for the latest updates on stock movements.Stay updated with the stocks that are on the move in Friday's pre-market session.
2 months ago - PepGen Inc.PepGen to Participate in Upcoming Investor ConferencesBOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...
2 months ago - PepGen Inc.PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular DystrophyBOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of...
2 months ago - InvestorPlacePEPG Stock Earnings: PepGen Beats EPS for Q4 2023PEPG stock results show that PepGen beat analyst estimates for earnings per share the fourth quarter of 2023.
2 months ago - BusinessInsiderPEPG Stock Earnings: PepGen Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips PepGen (NASDAQ:PEPG) just reported results for the fourth quarter of 2023.PepGe...
2 months ago - PepGen Inc.PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments- Enrollment completed for PGN-EDO51 5 mg/kg cohort in CONNECT1-EDO51 Phase 2 clinical trial in DMD patients. The Company expects to announce preliminary...
2 months ago - PepGen Inc.PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy2 months ago - PepGen Inc.PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
3 months ago - Seeking AlphaPepGen announces pricing of $80.1M underwritten offering (NASDAQ:PEPG)PepGen Inc. (PEPG) has priced its underwritten offering, expecting to raise approximately $80.1 million through the sale of its common stock.
